Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Aggregate statistics from Disclosed's verified COA corpus. All numbers are computed directly from lab-uploaded Certificates of Analysis — no editorial claims, no estimates.
COAs
9
Labs
5
Vendors tested
5
Avg purity
99.6%
±0.3%
Endotoxin tested
44%
of all COAs tested
Sterility tested
11%
of all COAs tested
Methodology:Purity averages exclude values outside [50%, 100%] to filter unit misreads. "Vendors tested" counts distinct vendor IDs across all in-scope, non-withdrawn, extracted COAs. Endotoxin/sterility coverage denominators are all in-scope COAs (not filtered to parenteral form).
Data updates hourly. All figures are computed from lab-uploaded COAs; Disclosed does not perform independent testing.
Based on 9 Certificates of Analysis in the Disclosed corpus, Livagen has an average HPLC purity of 99.6% (±0.3% std dev). This figure spans 5 vendors tested across 5 independent labs. Purity is measured by high-performance liquid chromatography (HPLC); values outside 50–100% are excluded as unit misreads.
5 distinct testing labs have produced COAs for Livagen in the Disclosed database, covering 9 total tests across 5 vendors.
44% of Livagen COAs in the Disclosed corpus include endotoxin test results (USP <85>), and 11% include sterility results (USP <71>). Endotoxin and sterility testing matter for injectable-grade peptides — their absence in a COA does not indicate failure, but absence is common in HPLC-only testing workflows.
Disclosed Labs